Abstract:Preimplantation diagnosis of the delta F508 deletion causing cystic fibrosis is possible through in vitro fertilization, biopsy of a cleavage-stage embryo, and amplification of DNA from single embryonic cells. This approach should be equally applicable to other single-gene diseases in which the defect has been identified. Analysis of a series of pregnancies, however, will be required to assess the method adequately.
“…The accuracy of diagnosis was higher in homozygous normal and affected blastomeres than in heterozy-gous blastomeres. The overall accuracy of PGD in this series was 91.5%, resulting in six homozygous unaffected healthy births (12)(13)(14).…”
Section: Preimplantation Diagnosis Of Single-gene Disordersmentioning
“…The accuracy of diagnosis was higher in homozygous normal and affected blastomeres than in heterozy-gous blastomeres. The overall accuracy of PGD in this series was 91.5%, resulting in six homozygous unaffected healthy births (12)(13)(14).…”
Section: Preimplantation Diagnosis Of Single-gene Disordersmentioning
“…Soon after these early PGD cases, PCR-based protocols were developed for inherited diseases such as cystic fibrosis and α-1-antitrypsin. These tests involved the amplification of the DNA fragment which contained the causative mutation and its detection using mutation analysis techniques [4,5].…”
Section: Diagnosis Of Single Gene Defectsmentioning
“…Les progrès techniques ont ensuite permis la réalisation du premier DPI de mucoviscidose en 1992 [2] qui a donné naissance au concept du « bébé du double espoir ». Les décrets ne sont pourtant pas publiés un an après, ce qui pose de difficiles problèmes pour les couples en attente.…”
Section: Dpi : La Réglementation Françaiseunclassified
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.